Evidence map›Paper›PMID 42252849›Full record

ArticleBritish journal of haematology2026

Real-world application of the International Myeloma Society (IMS)/International Myeloma Working Group (IMWG) consensus on genomic staging for high-risk multiple myeloma: A report from the Australia and New Zealand Myeloma and Related Diseases Registry.

Kenneth J C Lim, Elham Ashrafi, Cameron Wellard, Elizabeth M Moore, Betty Gration, Bradley Augustson, Peter Mollee, Jennifer Zhang, Nicole Wong Doo, Karen Dun and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Kenneth J C LimAustralian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-2664-116X
Elham AshrafiSchool of Public Health and Preventative Medicine, Monash University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0001-8640-0168
Cameron WellardSchool of Public Health and Preventative Medicine, Monash University, Melbourne, Victoria, Australia.
Elizabeth M MooreSchool of Public Health and Preventative Medicine, Monash University, Melbourne, Victoria, Australia.
Betty GrationSt Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
Bradley AugustsonSir Charles Gairdner Hospital, Perth, Western Australia, Australia.
Peter MolleeDepartment of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Jennifer ZhangConcord Repatriation General Hospital, Sydney, New South Wales, Australia.
Nicole Wong DooConcord Repatriation General Hospital, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0003-3725-3397
Karen DunVictorian Cancer Cytogenetic Service, Melbourne, Victoria, Australia.
Rachel CookeNorthern Health, Melbourne, Victoria, Australia.
Sabine RingkowskiLiverpool Hospital, Sydney, New South Wales, Australia.
Adam BryantLiverpool Hospital, Sydney, New South Wales, Australia.ORCID https://orcid.org/0009-0000-1621-4327
Georgia McCaughanSt Vincent's Hospital Sydney, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0002-4838-9022
Erica WoodSchool of Public Health and Preventative Medicine, Monash University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0001-7527-2340
Zoe McQuiltenSchool of Public Health and Preventative Medicine, Monash University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0001-9698-7185
P Joy HoThe Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0002-2811-8671
Hang QuachSt Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
Andrew SpencerAustralian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-0531-7424

Funding

AbbvieAmgenAntengene Corporation LimitedBristol-Myers SquibbCelgeneGileadGlaxoSmithKlinJohnson & Johnson Innovative MedicineNovartisPfizerRocheSanofiTakeda Pharmaceutical Company
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

consensus genomic stagingcytogeneticsfunctional high‐risk diseasehigh‐risk multiple myelomamultiple myelomareal‐worldrisk stratification

Identifiers

PMID42252849
PMCPMC13462172

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.